Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB

非酒精性脂肪肝 内分泌学 内科学 脂肪肝 活性氧 炎症 油红O CD86 生物 化学
作者
Yu Zhu,Shuiliang Ruan,Heping Shen,Qiaobing Guan,Liping Zhai,Yi Yang
出处
期刊:International Immunopharmacology [Elsevier]
卷期号:101: 108290-108290
标识
DOI:10.1016/j.intimp.2021.108290
摘要

• Ori suppressed ROS production and regulated the M1 polarization of KCs, thus protecting the liver in NAFLD. • Regulating the M2 polarization of KCs can inhibit NAFLD inflammation and promote liver recovery. • ROS is an important signal that regulates the M2 polarization of KCs cells. Oridonin (Ori) is a kind of diterpenoid small molecule, but its role in nonalcoholic fatty liver disease (NAFLD) has not been reported yet. This study aimed to explore the pharmacological function of Ori in liver protection through the reactive oxygen species (ROS)-mediated polarization of Kupffer cells (KCs). In the present work, KCs were adopted for study in vitro. To be specific, LPS and IFN-γ were utilized to induce M1 polarization, then the influence of Ori intervention on the expression of inflammatory factors IL-1β, IL-6 and TNF-α was detected by enzyme-linked immunosorbent assay (ELISA), that of CD86 and P 65 was measured through fluorescence staining, that of p- P 65 and p-P50 was detected by Western blotting (WB) assay, and ROS expression was measured by using the DCFH-DA probe. The C57BL/6J mice were fed with the high fat diet (HFD) to construct the NAFLD model, and intervened with Ori. The blood glucose (BG), body weight (BW), food intake and water intake of mice were monitored; meanwhile, glucose and insulin tolerance tests were conducted. The liver tissues of mice were subjected to H&E staining and oil red O staining. Moreover, the serum ALT, AST and TG levels in mice were monitored, the CD86 and CD206 levels were measured through histochemical staining, the expression of inflammatory factors was detected by ELISA, and the p- P 65 and p-P50 protein levels were detected by WB assay. Ori suppressed the M1 polarization of KCs, reduced the levels of inflammatory factors, and decreased the expression of ROS, p- P 65 and p-P50. In animal experiments, Ori improved lipid deposition and liver injury in the liver tissues of NAFLD mice, increased the proportion of M2 cells (up-regulated CD206 expression), reduced that of M1 cells (down-regulated CD86 expression), and decreased the serum ALT, AST and TG levels. This study discovered that Ori suppressed ROS production and regulated the M1 polarization of KCs, thus protecting the liver in NAFLD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
蛋壳柯发布了新的文献求助10
1秒前
搜集达人应助hwezhu采纳,获得10
1秒前
pain豆先生完成签到 ,获得积分10
3秒前
Chris发布了新的文献求助10
6秒前
超级的鞅完成签到,获得积分10
9秒前
9秒前
丘比特应助阿媛呐采纳,获得30
10秒前
悦耳觅荷发布了新的文献求助20
12秒前
蛋壳柯完成签到,获得积分10
12秒前
慕青应助王弈轩采纳,获得10
12秒前
DPY发布了新的文献求助10
13秒前
景代丝发布了新的文献求助10
13秒前
Akim应助顺利的万宝路采纳,获得10
15秒前
16秒前
17秒前
18秒前
20秒前
Artemis发布了新的文献求助20
20秒前
清风发布了新的文献求助10
21秒前
秋雪瑶应助玮哥不是伟哥采纳,获得10
23秒前
wanci应助hwezhu采纳,获得10
23秒前
三气诸葛亮完成签到,获得积分10
23秒前
Emper发布了新的文献求助10
25秒前
王弈轩发布了新的文献求助10
26秒前
28秒前
Jasper应助xialuoke采纳,获得10
28秒前
29秒前
小二郎应助deeferf采纳,获得30
32秒前
34秒前
YY完成签到,获得积分10
36秒前
xxzq完成签到,获得积分20
36秒前
cjhsci发布了新的文献求助10
37秒前
37秒前
39秒前
39秒前
王弈轩完成签到,获得积分20
40秒前
40秒前
11完成签到,获得积分10
41秒前
飞翔的帅猪完成签到,获得积分10
41秒前
专一的猎豹完成签到,获得积分10
42秒前
高分求助中
Teaching Social and Emotional Learning in Physical Education 900
Plesiosaur extinction cycles; events that mark the beginning, middle and end of the Cretaceous 800
Recherches Ethnographiques sue les Yao dans la Chine du Sud 500
Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism 500
Chinese-English Translation Lexicon Version 3.0 500
Wisdom, Gods and Literature Studies in Assyriology in Honour of W. G. Lambert 400
薩提亞模式團體方案對青年情侶輔導效果之研究 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2392748
求助须知:如何正确求助?哪些是违规求助? 2097111
关于积分的说明 5284057
捐赠科研通 1824781
什么是DOI,文献DOI怎么找? 910020
版权声明 559943
科研通“疑难数据库(出版商)”最低求助积分说明 486287